Company news
Precipio, Inc. news in 2021
Precipio, Inc.'s news releases, calls and decks from 2021, newest first.
New York State Approves Precipio’s HemeScreen for POL clinical use
November 17, 2021
Precipio Announces Q3-2021 and year-end Shareholder Update Call
October 31, 2021
American Oncology Network Partners with Precipio to Bring HemeScreen® into AON’s Laboratory
August 25, 2021
Precipio Reschedules Q2-2021 Shareholder Update Call
August 19, 2021
Precipio Corrects Announcement of Q2-2021 Shareholder Update Call
August 12, 2021
Precipio Announces Q2-2021 and year-end Shareholder Update Call
August 11, 2021
Precipio Announces Preliminary Unaudited Q2-2021 Revenues of $2.3M
July 27, 2021
Precipio Terminates its Equity Line
June 14, 2021
Precipio Launches HemeScreen® Anemia Panel, a One-of-its-Kind Testing Tool
June 7, 2021
Precipio Announces Q1-2021 and year-end Shareholder Update Call
May 13, 2021
Precipio Launches New HemeScreen Panel for AML, with an unparalleled 4-hour turnaround-time
May 9, 2021
Precipio Launches its Rapid COVID-19 Antibody test on Amazon Platform
May 2, 2021
Current Signed Customers Expected to Generate $1M Annualized Reported Revenues from Precipio’s HemeScreen POL Offering by Q4-2021
April 25, 2021
Precipio Enters Into an At-The -Market (ATM) Financing Arrangement
April 4, 2021
Precipio Announces 95% Annual Growth YoY and 180% Quarterly Growth YoY
March 29, 2021
Precipio Announces Q4-2020 and year-end Shareholder Update Call
March 17, 2021
Mr. Ron Andrews joins Precipio’s Board of Directors
March 2, 2021
Mr. Richard Sandberg is appointed Chairman of Precipio’s Board of Directors
March 2, 2021
Precipio Launches COVID-19 Antibody Testing at Point-of-Care
January 27, 2021
Precipio Signs HemeScreen™ Deals with Two Leading Oncology Groups
January 19, 2021